ALVAC-CEA vaccine

Known as: ALVAC-CEA 
A cancer vaccine consisting of ALVAC, a highly attenuated poxvirus strain derived from the canarypox virus, encoding for the tumor associated antigen… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2015
0119972015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
PURPOSE The combination of vaccines and chemotherapy holds promise for cancer therapy, but the effect of cytotoxic chemotherapy… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2007
2007
Avipoxvirus-based vectors, such as recombinant canarypox virus ALVAC, are studied extensively as delivery vehicles for vaccines… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
Based on the observation that viral infection results in the presentation of virus-specific peptides in association with both MHC… (More)
Is this relevant?
Review
2002
Review
2002
Therion Biologics, in collaboration with Aventis Pasteur, is developing ALVAC-CEA/B7.1, a recombinant, pox virus-based vaccine… (More)
Is this relevant?
2001
2001
Granulocyte macrophage colony-stimulating factor (GM-CSF) has been shown to be an effective vaccine adjuvant because it enhances… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
 The generation of cytotoxic effector T cells requires delivery of two signals, one derived from a specific antigenic epitope and… (More)
Is this relevant?
2000
2000
Avipox viruses are replication-defective members of the poxvirus family. Avipox-derived vectors such as ALVAC (canarypox) and… (More)
Is this relevant?
2000
2000
Coordinated presentation of antigen and costimulatory molecules has been shown to result in the induction of an antigen-specific… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
PURPOSE A phase I clinical trial in patients with advanced carcinoma was conducted, using a replication-defective avipox vaccine… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Recombinant vaccinia viruses containing tumor associated genes represent an attractive vector to induce immune responses to weak… (More)
Is this relevant?